The Brazilian statutory exemption to pharmaceutical patents: beyond generics

摘要

Brazilian patent law offers a statutory exception related specifically to pharmaceutical patents. That exception has a unique importance to the new aspects of the intellectual property rights and to the rights to public health. This article will present this statutory exception and analyse the consequences of its application. The text relates to the new international trends that regulate pharmaceutical patents, especially the relation between pharmaceutical patents and public health.